HealthCor Management, L.P. Buys Edwards Lifesciences Corp, Humana Inc, Elanco Animal Health Inc, Sells Zimmer Biomet Holdings Inc, Allergan PLC, Haemonetics Corp

• New Purchases: EW, ELAN, BMY, AMRN, ALGN, CRL, ANTM, CHNG, CHNG, BPMC, ALNY, ALC, STML, NUVA, THC, PSNL, SYK, ADPT, ACAD,
• Added Positions: HUM, ABT, NBIX, NVRO, HCA, VRTX, HZNP, MDGL, CNMD, GILD, BLUE, BSX, SEM, XENT, CLVS, VRAY, MRK, PTE,
• Reduced Positions: HAE, MDT, DHR, RDUS, CNC, UNH, WMGI, IQV, MYOK, BDX, IRWD,
• Sold Out: ZBH, AGN, DXCM, ISRG, ICLR, TMO, PCRX, MDCO, IRTC, IOVA, BHVN, CBAY, DTIL, KPTI, CYCN,

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

1. Neurocrine Biosciences Inc (NBIX) - 2,371,390 shares, 7.79% of the total portfolio. Shares added by 56.41%
2. Humana Inc (HUM) - 644,860 shares, 6.65% of the total portfolio. Shares added by 149.81%
3. Edwards Lifesciences Corp (EW) - 622,230 shares, 4.47% of the total portfolio. New Position
4. Merck & Co Inc (MRK) - 1,292,410 shares, 4.22% of the total portfolio. Shares added by 2.83%
5. Madrigal Pharmaceuticals Inc (MDGL) - 1,032,270 shares, 4.21% of the total portfolio. Shares added by 15.73%

HealthCor Management, L.P. initiated holding in Edwards Lifesciences Corp. The purchase prices were between $167.22 and $193.23, with an estimated average price of $181.16. The stock is now traded at around $222.01. The impact to a portfolio due to this purchase was 4.47%. The holding were 622,230 shares as of .

HealthCor Management, L.P. initiated holding in Elanco Animal Health Inc. The purchase prices were between $31.11 and $34.79, with an estimated average price of $32.44. The stock is now traded at around $27.26. The impact to a portfolio due to this purchase was 3.79%. The holding were 2,879,010 shares as of .

HealthCor Management, L.P. initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $44.62 and $49.34, with an estimated average price of $46.57. The stock is now traded at around $47.63. The impact to a portfolio due to this purchase was 3.55%. The holding were 2,012,650 shares as of .

HealthCor Management, L.P. initiated holding in Amarin Corp PLC. The purchase prices were between $16.27 and $20.51, with an estimated average price of $18.3. The stock is now traded at around $15.43. The impact to a portfolio due to this purchase was 2.3%. The holding were 3,047,910 shares as of .

HealthCor Management, L.P. initiated holding in Align Technology Inc. The purchase prices were between $268.08 and $331.08, with an estimated average price of $301.8. The stock is now traded at around $174.50. The impact to a portfolio due to this purchase was 2.19%. The holding were 205,510 shares as of .

HealthCor Management, L.P. initiated holding in Charles River Laboratories International Inc. The purchase prices were between $123.4 and $148.55, with an estimated average price of $135.54. The stock is now traded at around $129.43. The impact to a portfolio due to this purchase was 2.01%. The holding were 364,413 shares as of .

HealthCor Management, L.P. added to a holding in Humana Inc by 149.81%. The purchase prices were between $232.89 and $276.48, with an estimated average price of $253.55. The stock is now traded at around $294.42. The impact to a portfolio due to this purchase was 3.99%. The holding were 644,860 shares as of .

HealthCor Management, L.P. added to a holding in Abbott Laboratories by 857.70%. The purchase prices were between $72.88 and $85, with an estimated average price of $78.62. The stock is now traded at around $84.54. The impact to a portfolio due to this purchase was 3.35%. The holding were 1,144,160 shares as of .

HealthCor Management, L.P. added to a holding in Neurocrine Biosciences Inc by 56.41%. The purchase prices were between $72.24 and $91.27, with an estimated average price of $82.02. The stock is now traded at around $97.03. The impact to a portfolio due to this purchase was 2.81%. The holding were 2,371,390 shares as of .

HealthCor Management, L.P. added to a holding in Nevro Corp by 377.73%. The purchase prices were between $58.04 and $66.99, with an estimated average price of $62.27. The stock is now traded at around $83.00. The impact to a portfolio due to this purchase was 2.45%. The holding were 1,227,730 shares as of .

HealthCor Management, L.P. added to a holding in HCA Healthcare Inc by 185.63%. The purchase prices were between $112.01 and $135.18, with an estimated average price of $126.22. The stock is now traded at around $123.19. The impact to a portfolio due to this purchase was 1.43%. The holding were 419,330 shares as of .

HealthCor Management, L.P. added to a holding in Vertex Pharmaceuticals Inc by 58.94%. The purchase prices were between $164.61 and $190.37, with an estimated average price of $174.67. The stock is now traded at around $183.72. The impact to a portfolio due to this purchase was 1.42%. The holding were 538,440 shares as of .

HealthCor Management, L.P. sold out a holding in Zimmer Biomet Holdings Inc. The sale prices were between $112.14 and $128.84, with an estimated average price of $120.53.

HealthCor Management, L.P. sold out a holding in Allergan PLC. The sale prices were between $115.73 and $167.43, with an estimated average price of $138.45.

HealthCor Management, L.P. sold out a holding in DexCom Inc. The sale prices were between $111.38 and $155.66, with an estimated average price of $125.45.

HealthCor Management, L.P. sold out a holding in Intuitive Surgical Inc. The sale prices were between $458.27 and $585.89, with an estimated average price of $513.67.

HealthCor Management, L.P. sold out a holding in Icon PLC. The sale prices were between $129.99 and $153.97, with an estimated average price of $140.11.

HealthCor Management, L.P. sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $257.51 and $295.55, with an estimated average price of $275.13.